Leal R, Pinto H, Galvão A, Santos L, Romãozinho C, Macário F, Alves R, Pratas J, Sousa V, Marinho C, Prado E Castro L, Campos M, Mota A, Figueiredo A
Nephrology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Nephrology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Transplant Proc. 2017 May;49(4):792-794. doi: 10.1016/j.transproceed.2017.01.066.
There is a high incidence of nephrotic proteinuria in renal transplant recipients, which is an accurate predictor of graft loss. Despite this, its histologic correlates and prognostic implications are still not well characterized. We assessed the clinical and histological correlates of kidney transplantation patients with nephrotic range proteinuria.
We have retrospectively analyzed clinical and histological data from 50 kidney transplantation biopsy specimens from 44 renal transplant recipients with nephrotic range proteinuria between 2006 and 2015. The median follow-up time was 93 months (range, 14 months to 190 months).
The mean age of the patients was 45.2 ± 13.7 years and our cohort included 86% recipients of deceased-donor grafts. The maintenance immunosuppressive regimen included calcineurin inhibitors in 68% and mammalian target of rapamycin inhibitors in 32% of patients. The average proteinuria was 6.9 ± 3.8 g/d and 52% of patients presented with nephrotic syndrome. The main histological findings were transplant glomerulopathy (22%), de novo glomerular disease (22%), and recurrence of primary disease (22%). Tubular atrophy and interstitial fibrosis was present in 78% of the biopsy specimens. Thirty-one patients (62%) lost the graft at follow-up. There was no statistically significant difference between the histologic diagnosis nor the proteinuria levels and the outcome of the graft.
The main causes of nephrotic range proteinuria in patients undergoing biopsy were transplant glomerulopathy, recurrence of the underlying disease, and de novo glomerulonephritis. Nephrotic range proteinuria was related to a high rate of graft loss.
肾移植受者中肾病性蛋白尿的发生率很高,它是移植肾丢失的准确预测指标。尽管如此,其组织学相关性和预后意义仍未得到充分表征。我们评估了肾病范围蛋白尿肾移植患者的临床和组织学相关性。
我们回顾性分析了2006年至2015年间44例肾病范围蛋白尿肾移植受者的50份肾移植活检标本的临床和组织学数据。中位随访时间为93个月(范围为14个月至190个月)。
患者的平均年龄为45.2±13.7岁,我们的队列包括86%的已故供体移植受者。维持免疫抑制方案包括68%的患者使用钙调神经磷酸酶抑制剂和32%的患者使用雷帕霉素靶蛋白抑制剂。平均蛋白尿为6.9±3.8g/d,52%的患者出现肾病综合征。主要组织学发现为移植肾小球病(22%)、新发肾小球疾病(22%)和原发性疾病复发(22%)。78%的活检标本存在肾小管萎缩和间质纤维化。31例患者(62%)在随访中移植肾丢失。组织学诊断、蛋白尿水平与移植肾结局之间无统计学显著差异。
接受活检患者中肾病范围蛋白尿的主要原因是移植肾小球病、基础疾病复发和新发肾小球肾炎。肾病范围蛋白尿与移植肾高丢失率相关。